Research progress in controlled attenuation parameter for assessment of fatty liver disease
-
摘要: 受控衰减参数(CAP)是一种无创、定量、快速、可靠的评估脂肪性肝病(FLD)的新方法,是当前无创诊断FLD的热点。介绍了与CAP评估FLD密切相关的因素、诊断肝脂肪变的临界值以及CAP测量失败和检测数据不可信的原因。认为虽然CAP无创定量诊断FLD的临床价值已经获得了较多研究报告认可,但是大多数研究结果的样本量相对较小,因此,CAP诊断肝脂肪变程度的临界值及影响其测量结果的相关因素依然需要大样本和多中心的研究报告进一步验证。Abstract: Controlled attenuation parameter(CAP) is a noninvasive,quantitative,fast,and reliable novel tool for the assessment of fatty liver disease(FLD),and it has been a hotspot in the noninvasive diagnosis of FLD.This paper introduces factors associated with CAP assessing FLD,the cut-off value for the diagnosis of liver steatosis,and the causes of the failure of CAP measurement and unreliable CAP measurement.The paper believes that even though the noninvasive and quantitative diagnosis of FLD by CAP has been confirmed by many studies,most of the results were obtained with a limited sample size.Therefore,the factors associated with the cut-off value for CAP diagnosing liver steatosis and factors influencing the measurement results still need validation with larger samples and multi-centered research reports.
-
Key words:
- fatty liver /
- controlled attenuation parameter /
- diagnosis /
- reviev
本文二维码
计量
- 文章访问数: 2584
- HTML全文浏览量: 47
- PDF下载量: 457
- 被引次数: 0